News
SCNI
4.270
+13.26%
0.500
Weekly Report: what happened at SCNI last week (0715-0719)?
Weekly Report · 4d ago
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
ASLAN Pharmaceuticals Limited's shares dipped 38.7% to $0.68 on Wednesday. The company's Singapore-incorporated subsidiary has filed for voluntary liquidation. Aptevo Therapeutics Inc. Shares climbed 84% after surging around 10% on Tuesday.
Benzinga · 07/17 17:28
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
The Dow Jones index rose more than 150 points on Monday. Goldman Sachs Group Inc. Reported better-than-expected results for its second quarter. Energy shares jumped by 2% on Monday; utilities shares fell by 1.8%. Asian markets closed mixed; European shares closed lower today.
Benzinga · 07/15 18:32
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
SolarEdge Technologies, Inc. Shares dipped 12.2% to $27.77 on Monday after the company announced a workforce reduction. Trump Media & Technology Group Corp. Shares rose 32.8% following the attempted assassination of Donald Trump. Shares of prison and firearm stocks traded higher following the attack.
Benzinga · 07/15 17:23
PLUG Stock Alert: Plug Power Gets Approval for HyVia Acquisition
Plug Power (NASDAQ:PLUG) stock is on the move Monday after the company got approval for its acquisition of HyVia. This approval comes from the EU and allows Plug Power to complete its join acquisition of the fuel cell company. PLUG stock started off down on Monday but is now up about 1% as of this afternoon. The company is also facing an antitrust probe overseas. Macy’s is calling off a take-private deal and Scinai Immunotherapeutics stock is rising today.
Investorplace · 07/15 16:41
M Stock Plunges 13% as Macy’s Calls Off Take-Private Talks
Macy’s stock is falling on Monday after the retailer called off talks of a deal that would have taken shares of M private. The company's shares are down 12.5% as of Monday afternoon. More than 15 million shares of Macy's are changing hands. The stock market news also has shares of Scinai Immunotherapeutics (NASDAQ:SCNI) up 56% today. Also, Cleveland-Cliffs (NYSE:CLF) stock and Amazon ( NASDAQ:AMZN) are down on Monday.
Investorplace · 07/15 16:22
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
U.S. Stocks traded higher midway through trading on Monday. The Nasdaq Composite rose more than 200 points. The Dow traded up 0.73% while the NASDAQ rose 1.16%. The NY Empire State Manufacturing Index fell to a reading of -6.6 in July. Energy shares jumped by 1.6% on Monday; utilities shares fell by 2.1%. Asian markets closed mixed in trading.
Benzinga · 07/15 16:05
Why Is Scinai Immunotherapeutics (SCNI) Stock Up 56% Today?
Scinai Immunotherapeutics (NASDAQ:SCNI) stock is up 55.8% as of Monday morning. The company announced results from an early study of a treatment for plaque psoriasis. Scinai has more than 26 million units of SCNI stock on the move today. Cleveland-Cliffs, Amazon and Super Micro Computer also have stock market news moving today.
Investorplace · 07/15 16:04
Scinai’s Psoriasis Treatment Shows Promising Results
TipRanks · 07/15 15:29
Scinai Immunotherapeutics Advances with Promising Q1 Results
TipRanks · 07/15 15:29
Scinai stock soars 54% on preclinical study for psoriasis drug
Scinai stock soars 54% on preclinical study for psoriasis drug. Israeli biotech reported positive results from a pre-clinical study of its NanoAb therapy candidate in the treatment of plaque Psoriasis. The company intends to conduct a first-in-human clinical trial in 2025.
Seeking Alpha · 07/15 15:08
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
The Dow Jones index gained more than 200 points on Monday. Information technology shares jumped by 1.1% in trading. The NY Empire State Manufacturing Index fell to a reading of -6.6 in July, compared to market estimates of -7.0. Asian markets closed mixed on Monday with the NASDAQ rising 0.52% and the S&P 500 up 0.44%.
Benzinga · 07/15 13:47
Weekly Report: what happened at SCNI last week (0708-0712)?
Weekly Report · 07/15 09:33
Scinai Immunotherapeutics’ Key Shareholder Meeting
TipRanks · 07/08 21:47
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 07/08 18:00
Scinai Immunotherapeutics Eyes Debt-Equity Swap
TipRanks · 07/08 17:18
Scinai Immunotherapeutics Strives for Nasdaq Compliance
TipRanks · 07/08 16:59
Weekly Report: what happened at SCNI last week (0701-0705)?
Weekly Report · 07/08 09:33
Scinai Immunotherapeutics GAAP EPS of $0.00
Seeking Alpha · 07/03 11:38
SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q1 2024
Scinai Immunotherapeutics just reported results for the first quarter of 2024. The company did not report any revenue for the quarter. Scinai reported earnings per share of -0.1 cent and no revenue in the quarter, according to the company's report.
Investorplace · 07/02 17:52
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.